Skip to content
BOLUS

Signal from the log

CAD Therapeutics

4 M$ · United States · Biotech

CAD Therapeutics, société new-yorkaise, déclare un Form D de 4 M$ placés sur 10 M$ autorisés auprès de deux investisseurs, première vente le 17 septembre. Aucun communiqué ne nomme les investisseurs.

Spotted

Announced on , logged by the watch of 2 October 2026.

Operation
Funding round
Announced amount
4 M$
Country
United States
Sector
Biotech

What the log says

Editorial note, in French

Dépôt réglementaire repéré à la SEC. La levée n'est pas encore documentée publiquement, aucun fonds n'y est nommé.

What is missing before publishing
  • No fund is publicly named. It is the first condition of the selection bar: without a named investor there is no round to tell.
  • The stage of the round is not disclosed. A letter is never inferred from an amount or a track record.
Provenance
Source edgar
Logged on 2 October 2026
Description Written in French during the watch run. Based on the headline as relayed by the source, without reading the issuer's press release.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Spotted The collection saw this operation and logged it. Nobody has processed it yet, so what is shown is still an automatic reading of the source headline.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.

One address, nothing else.

One letter a week, on Fridays: the week's funding rounds, the funds named, the amounts double checked. The list is never sold, one click to unsubscribe. The letter is written in French.

You are, if you care to say

Email confirmation before any subscription. The list is never sold. What Bolus knows about you is written on the privacy page (in French).